Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Nutex HealthNUTX +0.05%75 12-1 Month Momentum % is 65.63% as of Aug. 28, 2026. GuruFocus rates NUTX with a GF Score™ of 75/100 and a GF Value™ of $82.60 (Significantly Overvalued). The stock has 6 warning signs investors should review. Among 658 Healthcare Providers & Services companies, Nutex Health ranks better than 92.71% on this metric.
12-1 Month Momentum % is the total return of the stock from 12-month ago to 1-month ago. As of today (2026-08-28), Nutex Health's 12-1 Month Momentum % is 65.63%.
The industry rank for Nutex Health's 12-1 Month Momentum % or its related term are showing as below:
NUTX's 12-1 Month Momentum % is ranked better than 92.71% of 658
companies
in the Healthcare Providers & Services industry
Industry Median: -13.89
vs NUTX: 65.63
Nutex Health (NAS:NUTX) 12-1 Month Momentum % Explanation
Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 12-1 Month Momentum % measures the total return to a stock over the past twelve months, but ignores the previous month.
The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.
Nutex Health 12-1 Month Momentum % Related Terms
NUTX vs USPH, AMN, GMRS: 12-1 Month Momentum % Comparison
For the Medical Care Facilities subindustry, Nutex Health's 12-1 Month Momentum %, along with its competitors' market caps and 12-1 Month Momentum % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Nutex Health 12-1 Month Momentum % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Nutex Health's 12-1 Month Momentum % distribution charts can be found below:
* The bar in red indicates where Nutex Health's 12-1 Month Momentum % falls into.
Nutex Health (NAS:NUTX) 12-1 Month Momentum % Calculation
12-1 Month Momentum % is calculated as following:
12-1 Month Momentum %
=
( Price 1-month ago
/
Price 12-month ago
- 1 )
*
100 %
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Nutex Health (NUTX) has a 12-1 Month Momentum % of 65.63% as of Aug. 28, 2026. 12-1 Month Momentum measures the total return of the stock from 12-month ago to 1-month ago. View historical data on Nutex Health and its competitors. According to the industry distribution chart, Nutex Health ranks #48 out of 658 companies in the Healthcare Providers & Services industry, placing it in the top 7.3%.
Is Nutex Health's 12-1 Month Momentum % too high?
Nutex Health's current 12-1 Month Momentum % is 65.63%. Based on the distribution chart, Nutex Health ranks #48 out of 658 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Nutex Health has a GF Score™ of 75/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Nutex Health's 12-1 Month Momentum % compare to USPH and AMN?
According to the Healthcare Providers & Services industry distribution chart, Nutex Health ranks #48 out of 658 companies for 12-1 Month Momentum %. This places Nutex Health in the top 7% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 12-1 Month Momentum % for a Healthcare Providers & Services company?
A good 12-1 Month Momentum % depends on the Healthcare Providers & Services industry context. However, 12-1 Month Momentum % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 12-1 Month Momentum % mean?
A high 12-1 Month Momentum % can signal that a stock is expensive relative to its fundamentals. 12-1 Month Momentum measures the total return of the stock from 12-month ago to 1-month ago. View historical data on Nutex Health and its competitors. Nutex Health's current 12-1 Month Momentum % is 65.63%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nutex Health stock overvalued right now?
Based on GuruFocus' analysis, Nutex Health (NUTX) is currently considered Significantly Overvalued. The stock's GF Value™ is $82.60, compared to a current price of $194.00 — trading 134.9% above its estimated fair value. The current 12-1 Month Momentum % is 65.63%. Nutex Health's overall GF Score™ is 75/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 12-1 Month Momentum % calculated?
12-1 Month Momentum % is calculated from a company's financial statements. For Nutex Health (NUTX), the current 12-1 Month Momentum % is 65.63% as of Aug. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Nutex Health (NUTX) Overvalued in 2026?
Based on GuruFocus' analysis, Nutex Health stock appears to be overvalued.
The current stock price of $194.00 is trading 134.9% above its estimated GF Value™ of $82.60.
GuruFocus considers Nutex Health to be Significantly Overvalued.
Key valuation signals for NUTX:
12-1 Month Momentum %: 65.63%
GF Value™: $82.60 vs. price of $194.00 (134.9% above fair value)
No single metric tells the full story. See the NUTX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Nutex Health Inc is a physician-led, healthcare services and operations company with various hospital facilities in the U.S. states (hospital division), and a primary care-centric, risk-bearing population health management division. The company has three segments: the hospital division, the PHM division, and the real estate division. The hospital division implements and operates health care models, including micro-hospitals, specialty hospitals and hospital outpatient departments (HOPDs). The population health management (PHM) division owns and operates provider networks such as independent physician associations (IPAs). The Real Estate Entities own the land and hospital buildings which are leased to its hospital entities. The majority of the revenue is derived from the Hospital division.
75GF Score
Get the complete analysis for NUTX
12-1 Month Momentum % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NUTX has been successfully added to your 
